Evidence map›Paper›PMID 31452929›Full record

Observational studyRMD open2019

Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort.

Guillaume Morelle, Julie Gueudry, Florence Uettwiller, Carine Wouters, Brigitte Bader-Meunier, Mathieu P Robert, Dominique Monnet, Bahram Bodaghi, Martine Grall-Lerosey, Pierre Quartier

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in RMD open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Chronic Uveitis in Children.Indian journal of pediatrics · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Guillaume MorelleRAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, Hématologie et Rhumatologie Pédiatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France.ORCID 0000-0001-6511-1674
Julie GueudryOphthalmology Department, Centre Hospitalier Universitaire de Rouen, Rouen, France.
Florence UettwillerPediatric Department, CHRU Tours, Tours, France.
Carine WoutersRAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, Hématologie et Rhumatologie Pédiatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France.
Brigitte Bader-MeunierRAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, Hématologie et Rhumatologie Pédiatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France.
Mathieu P RobertParis-Descartes University, Paris, France.
Dominique MonnetParis-Descartes University, Paris, France.
Bahram BodaghiOphthalmology Department, Reference Center in Rare Diseases, Hopitaux Universitaires Pitie Salpetriere-Charles Foix, Assistance Publique Hopitaux de Paris, Paris, France.
Martine Grall-LeroseyPediatrics Department, Centre Hospitalier Universitaire de Rouen, Rouen, France.
Pierre QuartierRAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, Hématologie et Rhumatologie Pédiatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France.ORCID 0000-0002-1769-549X
Délégation Paris 5 · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Rouen · FRCentre Hospitalier Universitaire de Tours · FRPediatrics and Genetics · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the demographics, aetiologies, complications, treatments and visual prognoses of chronic and recurrent non-infectious paediatric-onset uveitis in France. Methods: Descriptive, retrospective and bicentric study in patients whose disease started before 17 and who were followed up in two centres from January 2010 to May 2017. Results: We included 147 patients with 268 affected eyes. Eighty-two had juvenile idiopathic arthritis-associated chronic uveitis, 58 were antinuclear antibody (ANA) positive and 24 were ANA negative, 36 had idiopathic uveitis, 9 had enthesitis-related arthritis-associated uveitis, 9 had sarcoidosis-associated uveitis and 11 had other inflammatory aetiologies. These patients cumulated 161 complications: ocular hypertension, cataract, band keratopathy, macular oedema, optic disk oedema and decreased visual acuity, including permanent visual loss for 31 patients. The most used treatments were corticosteroid (CS) eye drops (82%), systemic CSs (34%), methotrexate (58%) and biologics (38%). At the latest follow-up, 45 patients had achieved remission of uveitis without any treatment, 56 had inactive uveitis on topical steroids and 48 still had active uveitis. Conclusion: Paediatric-onset uveitis are associated with a high rate of complications. However, following the introduction of biologics and particularly antitumour necrosis factor alpha antibodies, a significant proportion of uveitis became inactive on or even off treatment.

Indexed as

AdolescentAdrenal Cortex HormonesAntibodies, AntinuclearArthritis, JuvenileBiological FactorsCataractChildChild, PreschoolChronic DiseaseFemaleFranceGlaucomaHumansImmunosuppressive AgentsInfantMacular EdemaAdrenal Cortex HormonesAntibodies, AntinuclearBiological FactorsImmunosuppressive AgentsMethotrexateanti-TNFjuvenile idiopathic arthritistreatment

Identifiers

PMID31452929
PMCPMC6691513
OpenAlexW2966672483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.